In the present study, contrast-enhanced MRI radiomics was demonstrated to be capable to predict therapeutic response in hepatocellular carcinoma treated with transcatheter arterial chemoembolization, which will provide some guidance for treatment decisions.
This abstract and the presentation materials are available to members only; a login is required.